Moreover, the exogenous inhibition of DDR or inherent DDR defects have been reported to induce expression of immune checkpoint proteins in cancer cells, for example, increased PD-L1 expression in MMR-deficient (MMR-D) cells compared with MMR-proficient (MMR-P) cells (Figure 4) [88]. Here, MRC1 is linked to cancer.